I often get asked about where things stand with stem cell therapy for back pain, which is the focus of today’s post. Back pain is a complex condition with many potential causes. New treatments are needed as existing approaches often don’t work that well. What about stem cells? Stem cell therapy or other cell therapy …
What if there was a likable person test that we could take to see how other people really view us scientists? How would that work? It turns out that a sense of likability might be more influential in academia than some of us might think, but it’s often problematic too. This came to mind because …
How many academic scientists could pass a likable person test? Read More »
It’s that time of year again when I grade my previous year’s predictions for the stem cell & regenerative medicine space. Overall, I did better than a typical year. I give the 2022 predictions an A- overall. This exercise can be kind of fun but also humbling. For example, I tend to be too optimistic …
Grading my 2022 regenerative medicine predictions Read More »
I’m working to send out a big grant on Tuesday so I’m busier than ever but a few stem cell and regenerative medicine stories caught my eye. I can’t write grants 24/7 without a few breaks although sometimes it feels like that’s what I’m doing. Bat stem cell derivation Pluripotent bat stem cells as a …
Weekly stem cell reads: bat stem cells, brainier organoids, more Read More »
There’s nothing quite like getting a new paper out as a scientist running a research lab so this week we can celebrate our new pediatric brain tumor study. I’ll start the weekly reads with that paper. Of course, getting new grants is amazing too but there’s more of a feel of completion after a paper …
Weekly reads: our new brain tumor paper, levitation, dear doctor, Japan, more Read More »
At the beginning of the year I wrote about a new kind of biotech called Altos Labs. It’s very different in some ways from other institutions. I find it an intriguing research entity. Where do things stand now with Altos Labs a few months later? More information, new ideas, and questions have popped up in the …
Science must go on and so must stem cell meetings in 2022 with all those great conferences out there, but hopefully this year will be better than 2020-2021. It seems that way with the pandemic easing in the U.S. and many other places. On the other hand, COVID is spiking in Asia and other regions. …
Hub of Regenerative Medicine & Stem Cell Meetings 2022 Read More »
I wrote briefly a few months ago about Altos Labs. It’s a new kind of biotech institute that is focused on cellular reprogramming. Now we know much more and it’s clear this is a huge deal. What’s in this article What is Altos Labs? | Cellular rejuvenation | Reprogramming oldness | Challenges | Altos Strategies | Analysis of …
All about Altos Labs & its $3B cellular rejuvenation push Read More »
The fact that a person for the first time has received a heart transplant from a pig and it was a genetically modified pig made big news this week. Organ transplant waiting lists are a huge problem so if this kind of approach can be proven to be safe and effective, it would be a …
Recommended reads: pig heart transplant, lasers, $11K pub fee Read More »
Something called NIH continuous submission for frequent grant reviewers is now a thing of the past. This is kind of a big deal. It’s got to be a challenge for the NIH to get enough qualified reviewers to serve on study sections as grant reviewers. The recruitment of reviewers just probably got even harder with …
NIH continuous submission for frequent ad hoc reviewers is quietly dropped Read More »